Survivors of sepsis are at high risk for the development of chronic kidney disease (CKD), cardiovascular events and mortality. Mitochondrial dysfunction, which mainly results from increased generation of free radicals, plays a key role in the…
ID
Bron
Verkorte titel
Aandoening
infection, sepsis, mitochondrial dysfunction
Ondersteuning
Onderzoeksproduct en/of interventie
Uitkomstmaten
Primaire uitkomstmaten
The primary objective of the current project is to study the association between biomarkers for renal mitochondrial damage in sepsis with the change in renal function and mortality after sepsis.
Achtergrond van het onderzoek
Mitochondrial dysfunction plays a central role in the pathophysiology of AKI during sepsis, which is in turn associated with increased in-hospital and long-term mortality, as well as an increased risk of CKD among survivors. In this project, we will analyze whether the induction of damage to renal mitochondria during sepsis is associated with a declining renal function, cardiovascular events, co-morbidity, quality of life, functional status and mortality after sepsis.
Although great interindividual variability in ropivacaine concentration was found, both total and unbound maximum serum concentrations remained below the assumed systemic toxic thresholds in all samples.
Doel van het onderzoek
Survivors of sepsis are at high risk for the development of chronic kidney disease (CKD), cardiovascular events and mortality. Mitochondrial dysfunction, which mainly results from increased generation of free radicals, plays a key role in the pathogenesis of organ failure during sepsis. While adults are at high risk for acute kidney injury (AKI), elderly are in addition at major risk for acute delirium. Although aging-related damage to mitochondrial DNA (mtDNA) is associated with the development of CKD and (fatal) cardiovascular events, it is not known whether sepsis induces similar changes in mitochondria, which may in turn lead to increased morbidity and mortality after sepsis.
Onderzoeksopzet
Inclusion, day 4, 3 months, 1 year, 2 years
Onderzoeksproduct en/of interventie
n/a; observational study
Publiek
Wetenschappelijk
Belangrijkste voorwaarden om deel te mogen nemen (Inclusiecriteria)
- Adult patients, aged between 18 and 85 years
- Able to provide (deferred) informed consent themselves or informed consent can be obtained via next of kin or legal guardian
- One or both of the following:
o Clinical suspicion of a pulmonary or urinary tract infection
o Fever (body temperature > 38.5°C)
Belangrijkste redenen om niet deel te kunnen nemen (Exclusiecriteria)
A potential subject who meets any of the following criteria will be excluded from participation in this study:
- Discharged home without hospital admittance after ED visit
- Congenital mitochondrial diseases
- Renal transplant recipients
- Hepatic failure (Child Pugh C)
- Hepatorenal syndrome
- Start of antibiotics before blood sampling
Opzet
Deelname
Voornemen beschikbaar stellen Individuele Patiënten Data (IPD)
Opgevolgd door onderstaande (mogelijk meer actuele) registratie
Geen registraties gevonden.
Andere (mogelijk minder actuele) registraties in dit register
Geen registraties gevonden.
In overige registers
Register | ID |
---|---|
NTR-new | NL6156 |
NTR-old | NTR6303 |
Ander register | METC : 2017/077 |